Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

Nature Clinical Practice Neurology volume 3, pages 14–15 (2007)Cite this article

boxed-textvan den Bent MJ et al. (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24: 2715–2722

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Reardon DA et al. (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253–1265

    Article  CAS  PubMed  Google Scholar 

  2. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30 (Suppl 19): S10–S14

    Article  Google Scholar 

  3. Jaeckle KA et al. (2006) Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 24: 1246–1252

    Article  CAS  PubMed  Google Scholar 

  4. Macdonald DR et al. (1990) Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27: 573–574

    Article  CAS  PubMed  Google Scholar 

  5. Ino Y et al. (2000) Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 92: 983–990

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. MR Gilbert is Professor and Deputy Chair of the Department of Neuro-Oncology and FF Lang is Professor at the Department of Neurosurgery, both at the MD Anderson Cancer Center in Houston, TX, USA.,

    Mark R Gilbert & Frederick F Lang

Authors
  1. Mark R Gilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederick F Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark R Gilbert.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilbert, M., Lang, F. Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?. Nat Rev Neurol 3, 14–15 (2007). https://doi.org/10.1038/ncpneuro0375

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0375

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing